Ioxilan, a third generation low osmolality nonionic contrast medium systemic and renal hemodynamic effects

Richard W Katzberg, L. A. Donahue, T. W. Morris, J. A. Ventura, A. E. Krutchen, H. M. Proskin, M. Sovak, L. R. Cos

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The choice between high cost, low toxicity nonionic contrast media (CM) and low cost ionic CM poses a dilemma for radiologists. Ioxilan, a third generation nonionic CM, is obtained by simple conversion from an ionic CM. To examine how this economically promising, low osmolality CM (570 mOsm at 300 mgl/ml) affects canine systemic and renal hemodynamics, IV bolus injections of350 mgl/ml at 2 ml/kg of Iohexol and Ioxilan were compared. Satisfactory nephrograms and pyelograms were produced by both agents, without significant differences. The effects on systemic and renal hemodynamics were minimal and statistically equal for both CM. The acute systemic and renal responses and radiographic image quality of Ioxilan and Iohexol confirm that the two compounds are biologically equivalent, and that the novel molecular design employed in Ioxilan to achieve very low osmolality also provides good biological tolerance.

Original languageEnglish (US)
Pages (from-to)46-51
Number of pages6
JournalInvestigative Radiology
Volume25
Issue number1
StatePublished - 1990
Externally publishedYes

Fingerprint

Osmolar Concentration
Contrast Media
Hemodynamics
Kidney
Iohexol
Costs and Cost Analysis
Urography
ioxilan
Canidae
Injections

Keywords

  • Contrast media
  • Hemodynamics
  • Iohexol
  • Ionic
  • Ioxilan
  • Nonionic
  • Renal
  • Renal toxicity
  • Systemic
  • Toxicity
  • Urography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Katzberg, R. W., Donahue, L. A., Morris, T. W., Ventura, J. A., Krutchen, A. E., Proskin, H. M., ... Cos, L. R. (1990). Ioxilan, a third generation low osmolality nonionic contrast medium systemic and renal hemodynamic effects. Investigative Radiology, 25(1), 46-51.

Ioxilan, a third generation low osmolality nonionic contrast medium systemic and renal hemodynamic effects. / Katzberg, Richard W; Donahue, L. A.; Morris, T. W.; Ventura, J. A.; Krutchen, A. E.; Proskin, H. M.; Sovak, M.; Cos, L. R.

In: Investigative Radiology, Vol. 25, No. 1, 1990, p. 46-51.

Research output: Contribution to journalArticle

Katzberg, RW, Donahue, LA, Morris, TW, Ventura, JA, Krutchen, AE, Proskin, HM, Sovak, M & Cos, LR 1990, 'Ioxilan, a third generation low osmolality nonionic contrast medium systemic and renal hemodynamic effects', Investigative Radiology, vol. 25, no. 1, pp. 46-51.
Katzberg RW, Donahue LA, Morris TW, Ventura JA, Krutchen AE, Proskin HM et al. Ioxilan, a third generation low osmolality nonionic contrast medium systemic and renal hemodynamic effects. Investigative Radiology. 1990;25(1):46-51.
Katzberg, Richard W ; Donahue, L. A. ; Morris, T. W. ; Ventura, J. A. ; Krutchen, A. E. ; Proskin, H. M. ; Sovak, M. ; Cos, L. R. / Ioxilan, a third generation low osmolality nonionic contrast medium systemic and renal hemodynamic effects. In: Investigative Radiology. 1990 ; Vol. 25, No. 1. pp. 46-51.
@article{bfffcac46e3242f880c98f899e024474,
title = "Ioxilan, a third generation low osmolality nonionic contrast medium systemic and renal hemodynamic effects",
abstract = "The choice between high cost, low toxicity nonionic contrast media (CM) and low cost ionic CM poses a dilemma for radiologists. Ioxilan, a third generation nonionic CM, is obtained by simple conversion from an ionic CM. To examine how this economically promising, low osmolality CM (570 mOsm at 300 mgl/ml) affects canine systemic and renal hemodynamics, IV bolus injections of350 mgl/ml at 2 ml/kg of Iohexol and Ioxilan were compared. Satisfactory nephrograms and pyelograms were produced by both agents, without significant differences. The effects on systemic and renal hemodynamics were minimal and statistically equal for both CM. The acute systemic and renal responses and radiographic image quality of Ioxilan and Iohexol confirm that the two compounds are biologically equivalent, and that the novel molecular design employed in Ioxilan to achieve very low osmolality also provides good biological tolerance.",
keywords = "Contrast media, Hemodynamics, Iohexol, Ionic, Ioxilan, Nonionic, Renal, Renal toxicity, Systemic, Toxicity, Urography",
author = "Katzberg, {Richard W} and Donahue, {L. A.} and Morris, {T. W.} and Ventura, {J. A.} and Krutchen, {A. E.} and Proskin, {H. M.} and M. Sovak and Cos, {L. R.}",
year = "1990",
language = "English (US)",
volume = "25",
pages = "46--51",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Ioxilan, a third generation low osmolality nonionic contrast medium systemic and renal hemodynamic effects

AU - Katzberg, Richard W

AU - Donahue, L. A.

AU - Morris, T. W.

AU - Ventura, J. A.

AU - Krutchen, A. E.

AU - Proskin, H. M.

AU - Sovak, M.

AU - Cos, L. R.

PY - 1990

Y1 - 1990

N2 - The choice between high cost, low toxicity nonionic contrast media (CM) and low cost ionic CM poses a dilemma for radiologists. Ioxilan, a third generation nonionic CM, is obtained by simple conversion from an ionic CM. To examine how this economically promising, low osmolality CM (570 mOsm at 300 mgl/ml) affects canine systemic and renal hemodynamics, IV bolus injections of350 mgl/ml at 2 ml/kg of Iohexol and Ioxilan were compared. Satisfactory nephrograms and pyelograms were produced by both agents, without significant differences. The effects on systemic and renal hemodynamics were minimal and statistically equal for both CM. The acute systemic and renal responses and radiographic image quality of Ioxilan and Iohexol confirm that the two compounds are biologically equivalent, and that the novel molecular design employed in Ioxilan to achieve very low osmolality also provides good biological tolerance.

AB - The choice between high cost, low toxicity nonionic contrast media (CM) and low cost ionic CM poses a dilemma for radiologists. Ioxilan, a third generation nonionic CM, is obtained by simple conversion from an ionic CM. To examine how this economically promising, low osmolality CM (570 mOsm at 300 mgl/ml) affects canine systemic and renal hemodynamics, IV bolus injections of350 mgl/ml at 2 ml/kg of Iohexol and Ioxilan were compared. Satisfactory nephrograms and pyelograms were produced by both agents, without significant differences. The effects on systemic and renal hemodynamics were minimal and statistically equal for both CM. The acute systemic and renal responses and radiographic image quality of Ioxilan and Iohexol confirm that the two compounds are biologically equivalent, and that the novel molecular design employed in Ioxilan to achieve very low osmolality also provides good biological tolerance.

KW - Contrast media

KW - Hemodynamics

KW - Iohexol

KW - Ionic

KW - Ioxilan

KW - Nonionic

KW - Renal

KW - Renal toxicity

KW - Systemic

KW - Toxicity

KW - Urography

UR - http://www.scopus.com/inward/record.url?scp=0025099753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025099753&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 46

EP - 51

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

IS - 1

ER -